Foot volume increase on nifedipine is not prevented by pretreatment with diuretics

Journal of Hypertension

Volumn 22, Issue 2, 2004, Pages 425-430

  Van Der Heijden, Antoine G ^a   Huysmans, Frans Th M ^a   Van Hamersvelt, Henk W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Amiloride; Chlorthalidone; Diuretics; Hypertension; Nifedipine; Oedema

Indexed keywords

AMILORIDE; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIURETIC AGENT; NIFEDIPINE; PLACEBO; WATER;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; COLLOID; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; FOOT DISEASE; HEALTH STATUS; HEMATOCRIT; HUMAN; LEG EDEMA; MALE; OSMOTIC PRESSURE; PLASMA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VOLUNTEER;

EID: 1342280349     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200402000-00029     Document Type: Article

References (24)

1. Bauer JH, Reams G. Short-and long-term effects of calcium entry blockers on the kidney. Am J Cardiol 1987; 59:66A-71A.
2. MacGregor GA, Pevahouse JB, Cappuccio FP, Markandu ND. Nifedipine, sodium intake, diuretics, and sodium balance. Am J Nephrol 1987; 7 (suppl 1):44-48.
3. Messing M, Van Essen H, Smith TL, Smits JF, Struyker-Boudier HA. Microvascular actions of calcium channel antagonists. Eur J Pharmacol 1991; 198:189-195.
4. Gustafsson D, Lanne T, Bjerkhoel P, Johansson P, Lundvall J. Microvascular effects and oedema formation of felodipine in man. J Hypertens Suppl 1989; 7:S161-S167.
5. van Hamersvelt HW, Kloke HJ, de Jong DJ, Koene RA, Huysmans FT. Oedema formation with the vasodilators nifedipine and diazoxide: direct local effect or sodium retention? J Hypertens 1996; 14:1041-1045.
6. van Hamersvelt HW, van Kesteren M, Kloke HJ, Wetzels JF, Valk I, Koene RA, Huysmans FT. Ankle edema with nifedipine is not primarily due to sodium retention. J Am Soc Nephrol 1993; 4:541 (abstract).
7. Luscher TF, Waeber B. Efficacy and safety of various combination therapies based on a calcium antagonist in essential hypertension: results of a placebo-controlled randomized trial. J Cardiovasc Pharmacol 1993; 21:305-309.
8. Pickkers P, Hughes AD, Russel FG, Thien T, Smits P. Thiazide-induced vasodilation in humans is mediated by potassium channel activation. Hypertension 1998; 32:1071-1076.
9. Pickkers P, Garcha RS, Schachter M, Smits P, Hughes AD. Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide. Hypertension 1999; 33:1043-1048.
10. Peters G, Roch-Ramel F. Thiazide diuretics and related drugs. In: Eichler O, Farah A, Herken H, Welch AD (editors). Handbook of experimental pharmacology. New York: Springer-Verlag; 1969, pp. 258-382.
11. Puscas I, Coltau M, Baican M, Domuta G, Hecht A. Vasodilatory effect of diuretics is dependent on inhibition of vascular smooth muscle carbonic anhydrase by a direct mechanism of action. Drugs Exp Clin Res 1999; 25:271-279.
12. Golestaneh N, Klein C, Valamanesh F, Suarez G, Agarwal MK, Mirshahi M. Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton. Biochem Biophys Res Commun 2001; 280: 1300-1306.
13. Pickkers P, van Seek M, Hughes AD, Russel FG, Thien T, Smits P. Presence and mechanism of direct vascular effects of amiloride in humans. J Cardiovasc Pharmacol 1999; 34:388-393.
14. Lehoux S, Sirois MG, Sirois P, Plante GE. Acute and chronic diuretic treatment selectively affects vascular permeability in the unanesthetized normal rat. J Pharmacol Exp Ther 1994; 269:1094-1099.
15. Agnoli GC, Borgatti R, Cacciari M, Garutti C, Ikonomu E, Lenzi P, et al. Responses of the renal prostanoids to a short-term depletion of sodium or potassium in healthy women. Boll Soc Ital Biol Sper 1996; 72: 109-116.
16. Gustafsson D. Microvascular mechanisms involved in calcium antagonist edema formation. J Cardiovasc Pharmacol 1987; 10 (suppl 1): S121-S131.
17. Gustafsson D, Grande PO, Borgstrom P, Lindberg L. Effects of calcium antagonists on myogenic and neurogenic control of resistance and capacitance vessels in cat skeletal muscle. J Cardiovasc Pharmacol 1988; 12:413-422.
18. Iabichella ML, Dell'Omo G, Melillo E, Pedrinelli R. Calcium channel blockers blunt postural cutaneous vasoconstriction in hypertensive patients. Hypertension 1997; 29:751-756.
19. Valentin JP, Ribstein J, Halimi JM, Mimran A. Effect of different calcium antagonists on transcapillary fluid shift Am J Hypertens 1990; 3: 491-495.
20. Katzman PL, DiBona GF, Hokfelt B, Hulthen UL. Acute renal tubular and hemodynamic effects of the calcium antagonist felodipine in healthy volunteers. J Am Soc Nephrol 1991; 2:1000-1006.
21. DiBona GF, Sawin LL. Renal tubular site of action of felodipine. J Pharmacol Exp Ther 1984; 228:420-424.
22. Hannedouche T, Delgado A, Gnionsahe A, Lacour B, Grunfeld JP. Influence of nicardipine on renal hemodynamics and segmental tubular reabsorption of sodium in humans. J Cardiovasc Pharmacol 1989; 14:856-861.
23. van Hamersvelt HW, Wetzels JF, Kloke HJ, Koene RA, Huysmans FT. Angiotensin converting enzyme inhibition does not prevent the natriuretic effect of felodipine. J Cardiovasc Pharmacol 1993; 21:471-477.
24. McCrorey HL, Berl T, Burke TJ, DeTorrente A, Schrier RW. Effect of calcium transport inhibitors on renal hemodynamics and electrolyte excretion in the dog. In: Lichardus B, Schrier RW, Ponec J (editors). Hormonal regulation of sodium excretion. Amsterdam: Elsevier Biomedical Press, 1980:113-120.